
Product Portfolio Review
Categories
Date
23rd September 2021
The challenge
A UK pharmaceutical company with a diverse portfolio of unpromoted brands, wanted to better understand the potential to improve the performance of 6 brands in their portfolio, worth approximately £10m/yr.
With limited focus on the brands for several years, and internal resources focused on other portfolio needs, the company needed a complete external review to determine the best next steps.
The solution
Over six weeks, CHASE carried out a detailed analysis for the company including;
- Analysis of the relevant UK sales data and formulary statuses for the brands and competition
- Reviews of the commercial agreements in place with retail pharmacy, dispensing doctors, primary care and hospitals
- Assessments of the national, regional and local guidelines and guidance status of the brands
- Identification and assessment of new clinical data for the brands and competition
The outcomes
The external review identified growth opportunities for four of the brands
- Two brands required targeted customer promotion
- Retail pharmacy rebates for one brand were too high, with a potential upside of ~£100k/yr
- Hospital pharmacy engagement was required for one brand, where use vs. the main competitor did not reflect the brand’s 1st line formulary position
- CHASE is now working with the client to renew promotion of one of the brands reviewed

A New Prescription For Primary Care Brands

Joint Working - A Global Collaboration

Outsourced Key Account Management Team – Speed and Impact

Building Effectiveness & Confidence in Remote Customer Engagement

An Introduction to Remote Customer Engagement

High Calibre Graduate Recruitment

Challenging Recruitment Assignment – Area Business Managers

CHASE Performance vs CSO Competition

Graduates - Reinvigorate Existing Sales Organisation

CHASE – Maintaining Momentum Through Loss of Exclusivity Whilst Retaining Talent

Nurse Recruitment Success Where Others Failed

Identifying Resource Needs and a Customer-facing Team Structure

CHASE’s Effectiveness vs an RPO Global Agreement

Graduates Can Make A Positive Impact

Supporting New UK Ventures in Rare Diseases

Supporting a Specialist Product Launch with Hassle-free Outsourcing

Flexible Resourcing – Fast Deployment

Market Access – Regional Account Directors and Key Account Managers Competitive Recruitment

Identifying and Supporting the Right Candidate

Market Access Managers & Key Account Managers - Oncology

Specialist Key Account Managers – Secondary Care

Clinical Trial – Respiratory (COPD)

Successful Market Access Team Build

Hot-Spot Team – High Quality Delivered Quickly

Introducing Future Talent

Assessing the Market Potential of a New Medicine

Feasibility Project- Asthma Randomised Clinical Trial

Remote Selling Induction Programme – Preparing for Hybrid Selling